Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance
1. 系统已在2026-01-17 15:29:38对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.3c02182
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c02182
其他信息:
出版社: American Chemical Society (ACS)
作者: Meng Wang; Guimei Li; Guiyang Jiang; Jinyuan Cai; Zhikun Liu; Rizhen Huang; Xiaochao Huang; Hengshan Wang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c02182

